Press releases

Aiforia and X-ZELL partner to scale up novel AI-powered method for early cancer detection

Singapore, Helsinki -- Aiforia, a leading software company providing artificial intelligence (AI) solutions for medical image analysis, and X-ZELL, a clinical stage med-tech company aiming to make early, affordable cancer detection accessible to everyone, have entered into a strategic partnership to integrate X-ZELL’s novel rare cell detection technology with Aiforia’s deep learning AI software.